428 related articles for article (PubMed ID: 12755140)
21. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
24. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
25. Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
Wolfram RM; Brewer HB; Xue Z; Satler LF; Pichard AD; Kent KM; Waksman R
Am J Cardiol; 2006 Sep; 98(6):711-7. PubMed ID: 16950168
[TBL] [Abstract][Full Text] [Related]
26. Serial epidemiological surveys in an urban Indian population demonstrate increasing coronary risk factors among the lower socioeconomic strata.
Gupta R; Gupta VP; Sarna M; Prakash H; Rastogi S; Gupta KD
J Assoc Physicians India; 2003 May; 51():470-7. PubMed ID: 12974428
[TBL] [Abstract][Full Text] [Related]
27. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
28. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
[TBL] [Abstract][Full Text] [Related]
29. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly.
Mazza A; Tikhonoff V; Schiavon L; Casiglia E
Intern Med J; 2005 Oct; 35(10):604-10. PubMed ID: 16207260
[TBL] [Abstract][Full Text] [Related]
30. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
[TBL] [Abstract][Full Text] [Related]
31. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
32. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
33. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
34. Influence of total cholesterol levels on long-term mortality in coronary heart disease: a reappraisal.
Gupta R; Singh AK; Basira R; Gupta N; Kanodia A; Gupta KD
Indian Heart J; 2000; 52(1):23-8. PubMed ID: 10820929
[TBL] [Abstract][Full Text] [Related]
35. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
[TBL] [Abstract][Full Text] [Related]
36. Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous Familial Hypercholesterolemia.
Pitsavos CH; Chrysohoou C; Panagiotakos DB; Kokkinos P; Skoumas J; Papaioannou I; Michaelides AP; Singh S; Stefanadis CI
Atherosclerosis; 2004 Apr; 173(2):347-52. PubMed ID: 15064112
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
[TBL] [Abstract][Full Text] [Related]
38. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
[TBL] [Abstract][Full Text] [Related]
39. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
[TBL] [Abstract][Full Text] [Related]
40. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
